Kofi Kramo

Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial

D. Murphy, S. Cooray, S. Deb, 2008, The Lancet.

Reviewing the Evidence for NICE Recommended Psychotherapies for Depression

K. Kramo, Kofi Kramo, 2017 .

Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID).

S. Cooray, M. Crawford, P. Tyrer, 2009, Health technology assessment.

The great divide: A qualitative investigation of factors influencing researcher access to potential randomised controlled trial participants in mental health settings

M. Crawford, S. Patterson, K. Kramo, 2010, Journal of mental health.

Cognitive-behaviour therapy for health anxiety in medical patients (CHAMP): a randomised controlled trial with outcomes to 5 years.

P. Salkovskis, Duolao Wang, A. McNulty, 2017, Health technology assessment.

Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability : a randomised controlled trial. Commentary

S. Cooray, S. Bhaumik, B. Rao, 2008 .

Diversity learning through story and connection: Zhe: [noun] Undefined

K. Kramo, Lizette Nolte, Kofi Kramo, 2016, Clinical Psychology Forum.